Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,720.79
(
0.32%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

asmarterwookie

Send PM Follow Ignore
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

asmarterwookie

Re: north40000 post# 307850

Friday, 08/11/2017 9:28:06 AM

Friday, August 11, 2017 9:28:06 AM

Post# of 347009

On the ???s of patentabilities



Targeting was obvious IMHO. Anexin V does that, but wasn't that only to see the PS for Apoptosis reasons...just measuring PS exposure.

Targeting to effect PS signaling pathways is the new and important part. I HOPE!

ALSO, the ~30 hour duration of the binding affinity is new. Correct?

Is this a viable angle for patentability in your professional opinion?

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote